The observer-blind, randomised controlled study to determine the safety and immunogenicity of "Covishield" on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.
Read full Post
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment